STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout

A preliminary readout from a study could vindicate Allogene Therapeutics' stubborn belief in its off-the-shelf CAR-T treatment.
Source
Stat News
Opens original article in a new tab

